logo
Select company
Select metric
$ 152.2MCore Assets
VS
Market
30
Sector
58
Industry
67
History
100
$ 15.67Close
$ 5.56 - $ 16.49 52-Week Range
Ticker Information

Ticker

IMNM

Company Name

IMMUNOME INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUNOME INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMNM - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 296.29M$ 144.09M$ 152.2M$ 0
3/31/2025$ 342.69M$ 257.71M$ 84.98M$ 0
12/31/2024$ 240.24M$ 143.45M$ 96.79M$ 0
9/30/2024$ 256.9M$ 155.67M$ 101.23M$ 0
6/30/2024$ 296.21M$ 165.43M$ 130.78M$ 0
3/31/2024$ 319.75M$ 269.82M$ 49.93M$ 0
12/31/2023$ 148.54M$ 98.78M$ 49.76M$ 0
9/30/2023$ 93.16M$ 90.74M$ 2.42M$ 0
6/30/2023$ 41.44M$ 38.52M$ 2.92M$ 0
3/31/2023$ 48.11M$ 44.52M$ 3.59M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMMUNOME INC's latest trailing twelve months (TTM) Core Assets stands at $ 5.14M.
  • Over the past 5 years, IMMUNOME INC's average Core Assets has been $ 36.28M.
  • The median Core Assets for IMMUNOME INC during this period was $ 5.68M
  • IMMUNOME INC reached its highest Core Assets over the past 5 years at $ 152.2M.
  • The lowest Core Assets recorded by IMMUNOME INC in the same timeframe $ 2.42M

IMMUNOME INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
NUVB : NUVATION BIO INC $ 387.11MQURE : UNIQURE NV $ 230.17MZBIO : ZENAS BIOPHARMA INC $ 249.08MTSHA : TAYSHA GENE THERAPIES INC $ 17.97MABUS : ARBUTUS BIOPHARMA CORP $ 65.86MPRAX : PRAXIS PRECISION MEDICINES INC $ 295.42MLENZ : LENZ THERAPEUTICS INC $ 179.61MCAPR : CAPRICOR THERAPEUTICS INC $ 110.33MRLAY : RELAY THERAPEUTICS INC $ 612.64MVIR : VIR BIOTECHNOLOGY INC $ 868.27M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for IMMUNOME INC is calculated as follows: Assets [ $ 11.98M ] - Intangibles [ $ 0 ] - CashnEq [ $ 6.84M ]
(=) Core Assets [ $ 5.14M ]

IMNM - Core Assets, Last 5 years

$ 2.42M

Minimum

Sep 30, 2023

$ 152.2M

Maximum

Jun 30, 2025

$ 36.28M

Average

$ 5.68M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.36M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.36M
median$ 287.51M
std$ 1.05B